NCT06238765 CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
| NCT ID | NCT06238765 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CorEvitas |
| Condition | Atopic Dermatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2023-12-02 |
| Primary Completion | 2099-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2023-12-02 with a primary completion date of 2099-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.
Eligibility Criteria
Inclusion Criteria: * To be eligible to participate in this registry, an individual must meet all the following criteria: 1. Has been diagnosed with moderate to severe atopic dermatitis by a dermatologist or a qualified healthcare provider 2. Is 10 - 15 years of age at the time of enrollment. 3. Subject has initiated or is initiating an enrollment-eligible medication at the time of enrollment Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in the registry: 1. Is participating or planning to participate in a blinded clinical trial for an AD drug. 2. Is unwilling or unable to provide standing height measurements.
Frequently Asked Questions
Who can join the NCT06238765 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 15 Years, studying Atopic Dermatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06238765 currently recruiting?
Yes, NCT06238765 is actively recruiting participants. Visit ClinicalTrials.gov or contact CorEvitas to inquire about joining.
Where is the NCT06238765 trial being conducted?
This trial is being conducted at Waltham, United States.
Who is sponsoring the NCT06238765 clinical trial?
NCT06238765 is sponsored by CorEvitas. The trial plans to enroll 1,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.